Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repaymentsWages, Salaries and Other
Ratios

Nutex Health (NUTX) Short-Term Debt issuances (2016 - 2025)

Nutex Health (NUTX) has disclosed Short-Term Debt issuances for 6 consecutive years, with $437000.0 as the latest value for Q3 2025.

  • For Q3 2025, Short-Term Debt issuances fell 56.3% year-over-year to $437000.0; the TTM value through Mar 2026 reached $1.2 million, down 80.75%, while the annual FY2025 figure was $5.0 million, 122.94% up from the prior year.
  • Short-Term Debt issuances hit $437000.0 in Q3 2025 for Nutex Health, down from $742000.0 in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $3.9 million in Q1 2025 and bottomed at $89.0 in Q4 2023.
  • Average Short-Term Debt issuances over 5 years is $899279.2, with a median of $492474.5 recorded in 2022.
  • Year-over-year, Short-Term Debt issuances crashed 99.71% in 2023 and then skyrocketed 1269562.92% in 2024.
  • Nutex Health's Short-Term Debt issuances stood at $320430.0 in 2021, then tumbled by 90.4% to $30765.0 in 2022, then plummeted by 99.71% to $89.0 in 2023, then surged by 1269562.92% to $1.1 million in 2024, then tumbled by 61.33% to $437000.0 in 2025.
  • According to Business Quant data, Short-Term Debt issuances over the past three periods came in at $437000.0, $742000.0, and $3.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.